PGT-A in Screening of Embryos in the Treatment of Unexplained Recurrent Miscarriage

NCT04643938 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 69

Last updated 2020-11-25

No results posted yet for this study

Summary

uRM patients selected PGT-A from 2012 to 2016 were included in this study. Their clinical outcomes were prospectively observed and analyzed to explore the factor influenced the outcomes.

Conditions

  • Recurrent Early Pregnancy Loss

Sponsors & Collaborators

  • Peking University Third Hospital

    lead OTHER

Principal Investigators

  • Haiyan Wang, M.D. · Center of Reproductive Medicine, Peking University Third Hospital

Eligibility

Min Age
20 Years
Max Age
46 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2020-01-01
Completion
2020-02-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04643938 on ClinicalTrials.gov